FDA approves Botox for vertical platysma bands
The US Food and Drug Administration (FDA) has approved Allergan Aesthetics’ Botox Cosmetic (onabotulinumtoxinA) to treat moderate to severe vertical platysma bands. The approval was supported by phase III clinical